Forbes.com Healthcare News
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
906 records returned
Mammogram Debate Shows Why Reform Will Fail
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Why can't we control costs? Because experts who write perfectly reasonable guidelines get branded death panels. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 19, 2009 Category: Pharmaceuticals Source Type: news
ObamaCare: A Glimmer Of Hope For Cost ControlEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate's tax on Cadillac plans could save billions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Pilots Spring For LessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cirrus CEO Brent Wouters on a shift in buying habits sparked by the recession. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Answering The Vytorin QuestionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merck scores a PR win at a cardiology conference, but that doesn't mean its cholesterol drugs are effective. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Freelancers Vs. ObamaCareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
One-size-fits-all insurance reform could stamp out innovation that's already providing coverage and controlling costs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 17, 2009 Category: Pharmaceuticals Source Type: news
New Heart Pump Extends LivesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Device offers hope to the sickest heart failure patients. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Too Many MammogramsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Women can safely wait until age 50 to start getting them, an expert panel says. Get ready for the fireworks. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Another Vytorin Mess For MerckEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new study, though flawed, inflicts more damage on the company's Zetia and Vytorin cholesterol pills. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 15, 2009 Category: Pharmaceuticals Source Type: news
Layoffs Sting Big PharmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 13, 2009 Category: Pharmaceuticals Source Type: news
GM's Marketing CzarEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vice Chairman Bob Lutz pitted his Cadillac against all comers and got the best of them. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Good Medicine: When to Say No to Your DoctorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
How much of the $2.5 trillion we spend on health care goes down the drain for tests and treatments that don't help, run up the bill and may even cause harm? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Powerful Speaking The Obama WayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Three tips for delivering a message effectively like the President. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 11, 2009 Category: Pharmaceuticals Source Type: news
The Copenhagen Master PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Denmark readies for 15,000 to descend for the climate change conference. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 11, 2009 Category: Pharmaceuticals Source Type: news
AMA Uneasy In Support Of ObamaCareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The doctors group is pushing for reform to include a hike in Medicare reimbursements, but Congress may not play along. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 5, 2009 Category: Pharmaceuticals Source Type: news
Why Health Insurance Charges Are Going UpEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Despite strong earnings, HMOs are planning steep premium increases for next year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Genomics: No Longer A FailureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Mapping the human genome produced far more hype than drugs. That's starting to change. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 2, 2009 Category: Pharmaceuticals Source Type: news
Amgen's Anemic ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 31, 2009 Category: Pharmaceuticals Source Type: news
Living Without BlockbustersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 30, 2009 Category: Pharmaceuticals Source Type: news
Healing PowerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ultrasound is said to heal chronic wounds that don't respond to other treatments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 30, 2009 Category: Pharmaceuticals Source Type: news
Cancer Beats AstraZenecaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company pulls application for a promising experimental drug. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Hefty Side Effect For Kids On AntipsychoticsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Study finds troubling weight gains in children taking brand-name psychiatric drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Reviving TysabriEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The drug's inventor believes a new test might identify people who are less at risk for a deadly side effect. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Swine Flu Shot Gets Mexican TestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A vaccine for the 2009 H1N1 influenza virus made in insect cells could be approved in Mexico as early as next year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 20, 2009 Category: Pharmaceuticals Source Type: news
Poacher Joins GamekeepersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA appoints Peter Lurie, a major critic, to its Office of Policy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 18, 2009 Category: Pharmaceuticals Source Type: news
Biotechs Back From The DeadEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The financial crisis was supposed to annihilate small companies, but many survived. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 16, 2009 Category: Pharmaceuticals Source Type: news
Cobra AcheEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Poor insurance companies: Too many sick patients are signing up for coverage. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 15, 2009 Category: Pharmaceuticals Source Type: news
Medtronic's Passion PlayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Medical device maker to test stent as alternative to Viagra. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 14, 2009 Category: Pharmaceuticals Source Type: news
Little Turnaround For Big Pharma?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug stocks have sat out the rally so far, but with bargain basement valuations, that may be about to change. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 14, 2009 Category: Pharmaceuticals Source Type: news
Onyx To Buy Drugmaker For $276 MillionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The potential payoff from the purchase of tiny Proteolix is another big-selling cancer treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 12, 2009 Category: Pharmaceuticals Source Type: news
Pfizer Suspends Lung Cancer StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The news is another setback for Pfizer as it makes a big push into cancer drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 9, 2009 Category: Pharmaceuticals Source Type: news
The CybercureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From computer modeling to hospital robots, can information technology fix health care? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
R2D2 Has Your PillsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug-dispensing robots and smart medicine cabinets are helping to improve patient care. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
Health Record Gold RushEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Want to know what it's like in one of the country's most favored industries? Talk to Allscripts' Glen Tullman. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
The Disease MachineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Can software synthesize what we know about human biology into one clear picture? Stephen Friend thinks so. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
Wired Medicine's Silent GiantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The hottest company in the electronic medical records industry is a secretive Wisconsin outfit called Epic Systems. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
The Cyber CureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From computer modeling to hospital robots, can information technology fix health care? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 8, 2009 Category: Pharmaceuticals Source Type: news
Cancer ManEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patrick Soon-Shiong and one of cancer's biggest riddles. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 2, 2009 Category: Pharmaceuticals Source Type: news
A Long And Deadly WaitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sabril could help babies with brain-destroying seizures. So why did it take so long to approve? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 30, 2009 Category: Pharmaceuticals Source Type: news
Abbott's Solvay Deal: Don't Get Too ExcitedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The $6.6 billion purchase is about financial engineering, not acquiring new drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 28, 2009 Category: Pharmaceuticals Source Type: news
Dendreon Starts Growing UpEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A clear-eyed analyst meeting marks a turning point for the drugmaker. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 25, 2009 Category: Pharmaceuticals Source Type: news
Strange Bedfellows In The Baucus BrawlEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Medicare privatization has been a fiscal failure, yet it's now being hailed by ObamaCare opponents. Huh? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 23, 2009 Category: Pharmaceuticals Source Type: news
Sorry, No Magic Pill For Weight LossEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new obesity drug is safe, but it barely works. Will anyone use it? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 18, 2009 Category: Pharmaceuticals Source Type: news
A New Look At Alzheimer'sEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Have researchers been barking up the wrong tree? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2009 Category: Pharmaceuticals Source Type: news
A Baucus Bill FAQEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A quick look at how the Senate Finance Committee's plan might affect you and your business. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2009 Category: Pharmaceuticals Source Type: news
So Much For Single-PayerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
What's in the Baucus plan, what isn't and what it all means for the future of ObamaCare. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2009 Category: Pharmaceuticals Source Type: news
Obama Pulls Back To Go ForwardEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
After a summer of discontent ObamaCare has less ambition, but a better chance of passing. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 10, 2009 Category: Pharmaceuticals Source Type: news
Full Text: Rep. Boustany Delivers Republican Health Care AddressEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Full text of the Republican address on health care, delivered by Dr. Charles Boustany. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 10, 2009 Category: Pharmaceuticals Source Type: news
Where ObamaCare Goes From HereEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Something will get done, but there's a long road ahead. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 10, 2009 Category: Pharmaceuticals Source Type: news
A Bitter Aftertaste For French HospitalsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
My initial treatment at a public health system was great, but the aftercare was 'une catastrophe.' (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 4, 2009 Category: Pharmaceuticals Source Type: news
Global SystemsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Around the world medical care is a pastiche of different approaches--and nowhere more expensive than in America. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 4, 2009 Category: Pharmaceuticals Source Type: news
